Panagora Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,878
Closed -$294K 1394
2023
Q1
$294K Hold
16,878
﹤0.01% 1267
2022
Q4
$156K Buy
16,878
+499
+3% +$4.65K ﹤0.01% 1392
2022
Q3
$141K Hold
16,379
﹤0.01% 1396
2022
Q2
$133K Hold
16,379
﹤0.01% 1427
2022
Q1
$199K Hold
16,379
﹤0.01% 1463
2021
Q4
$559K Sell
16,379
-6,532
-29% -$256K ﹤0.01% 1173
2021
Q3
$1.1M Hold
22,911
0.01% 922
2021
Q2
$1.03M Sell
22,911
-5,056
-18% -$224K 0.01% 966
2021
Q1
$1.35M Sell
27,967
-16,525
-37% -$860K 0.01% 900
2020
Q4
$2.4M Sell
44,492
-5,614
-11% -$254K 0.01% 636
2020
Q3
$1.85M Sell
50,106
-96,150
-66% -$3.57M 0.01% 684
2020
Q2
$4.53M Sell
146,256
-172
-0.1% -$4.77K 0.03% 429
2020
Q1
$4.04M Hold
146,428
0.03% 402
2019
Q4
$4.28M Buy
146,428
+1,645
+1% +$39.2K 0.02% 533
2019
Q3
$2.77M Hold
144,783
0.01% 637
2019
Q2
$3.18M Buy
144,783
+130,812
+936% +$2.87M 0.01% 642
2019
Q1
$286K Hold
13,971
﹤0.01% 1586
2018
Q4
$176K Buy
+13,971
New +$208K ﹤0.01% 1662
2017
Q1
Sell
-106,558
Closed -$913K 2421
2016
Q4
$913K Sell
106,558
-3,204
-3% -$27.4K ﹤0.01% 1230
2016
Q3
$902K Buy
109,762
+72,287
+193% +$607K ﹤0.01% 1231
2016
Q2
$301K Buy
37,475
+11,373
+44% +$91.2K ﹤0.01% 1528
2016
Q1
$176K Sell
26,102
-170,947
-87% -$1.12M ﹤0.01% 1693
2015
Q4
$1.55M Buy
197,049
+32,705
+20% +$240K 0.01% 899
2015
Q3
$942K Sell
164,344
-1,094
-0.7% -$6.77K 0.01% 1054
2015
Q2
$895K Buy
165,438
+20,943
+14% +$108K ﹤0.01% 1145
2015
Q1
$675K Buy
144,495
+117,066
+427% +$509K ﹤0.01% 1211
2014
Q4
$114K Hold
27,429
﹤0.01% 1824
2014
Q3
$143K Sell
27,429
-22,087
-45% -$113K ﹤0.01% 1737
2014
Q2
$165K Buy
49,516
+14,699
+42% +$48.9K ﹤0.01% 1776
2014
Q1
$121K Buy
34,817
+12,555
+56% +$47K ﹤0.01% 1884
2013
Q4
$81K Sell
22,262
-15,778
-41% -$54.8K ﹤0.01% 1895
2013
Q3
$114K Buy
+38,040
New +$107K ﹤0.01% 1830

Other funds holding NEO

Panagora Asset Management's NEO Position: Q2 2023 in Review

Panagora Asset Management sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 16,878 shares — an estimated $294K sold.

Panagora Asset Management first reported a position in NEO in Q3 2013 and held it in 32 quarters. The position peaked at $4.53M in Q2 2020. 267 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Panagora Asset Management reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Panagora Asset Management sold 16,878 NeoGenomics shares in Q2 2023, an estimated $294K.
  • Panagora Asset Management first reported a position in NeoGenomics in Q3 2013 and held it in 32 quarters.
  • Panagora Asset Management's NeoGenomics position peaked at $4.53M in Q2 2020.
  • 267 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Panagora Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.